title: A possible influence of age on absorption and elimination of adalimumab in focal segmental glomerulosclerosis (FSGS).
authors.affiliation: CNRS, GICC UMR 7292, CHRU de Tours, Service de Pharmacologie-Toxicologie, Université François-Rabelais de Tours, 2 boulevard Tonnellé, 37044, Tours Cedex, France. david.ternant@univ-tours.fr.
authors.forename: David
authors.initials: D
authors.lastname: Ternant
authors.affiliation: CNRS, GICC UMR 7292, CHRU de Tours, Service de Pharmacologie-Toxicologie, Université François-Rabelais de Tours, 2 boulevard Tonnellé, 37044, Tours Cedex, France.
authors.forename: Gilles
authors.initials: G
authors.lastname: Paintaud
authors.affiliation: Division of Nephrology, NYU Langone Medical Center, New York, NY, USA.
authors.forename: Howard
authors.initials: H
authors.lastname: Trachtman
authors.affiliation: School of Medicine, Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
authors.forename: Debbie S
authors.initials: DS
authors.lastname: Gipson
authors.affiliation: Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, USA.
authors.forename: Melanie S
authors.initials: MS
authors.lastname: Joy
mesh_terms: D000068879:Adalimumab / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D005260:Female; D005923:Glomerulosclerosis, Focal Segmental / Q000378:metabolism*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008954:Models, Biological; D065566:Subcutaneous Absorption; D055815:Young Adult
chemical_list: D000068879:Adalimumab